A significant minority of people with depressive illness fail to respond to any currently available antidepressant medication. However, new methods of brain stimulation offer the possibility of relief from their symptoms...
- Mental Illnesses
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are hereDiscoveries ›
Next Generation Therapies
A team led by NARSAD Independent Investigator Grantee Alexander Neumeister, M.D., has provided evidence of dysfunction in a key brain system linked with the occurrence of PTSD. This new discovery holds promise as a target...
A recent 12-week study conducted by a team including John S. March, MD, MPH and Scott Compton, PhD indicates that cognitive behavioral therapy, in addition to medication, significantly improves the symptoms of OCD in...
Carlos A. Zarate, M.D., 2011 Outstanding Achievement in Mood Disorders Research Prizewinner, has pioneered research on rapid-acting antidepressants and their mechanism of action. One such drug is ketamine, which has been...
Dr. Aaron T. Beck, Foundation Distinguished Investigator, invented cognitive behavioral therapy decades ago and now demonstrates that it can successfully treat the ‘negative’ symptoms of schizophrenia, such as emotional...